Ionis Pharmaceuticals, Inc.
IONS NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 29, 2026
ET
EPS Est.
-1.08
EPS Actual
-0.69
Revenue Est.
$189.1M
Revenue Actual
$268M
Next Earnings Report
Date
Nov 4, 2026 · Wed
ET Nov 4, 2026 · Wed
Time
11/4 11:00-14:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-1.00
Revenue Est.
$181.6M
Company Overview
Ionis Pharmaceuticals, Inc. (ticker IONS) is listed on NASDAQ with a market cap of about $7.24B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), Pre-market, with consensus EPS of -1.00. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 22, 2023 → Jul 29, 2026
Feb 22, 2023Range: -1.41 ~ 0.86Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | -1.08 | Above forecast↑-0.69 | $189.1M | $268M |
| Apr 29, 2026 | -- | -0.85 | Above forecast↑-0.56 | $195.6M | $246M |
| Feb 25, 2026 | -- | -1.24 | Below forecast↓-1.41 | $156.1M | $203M |
| Oct 29, 2025 | -- | -1.15 | Above forecast↑-0.61 | $153.6M | $156.7M |
| Jul 30, 2025 | -- | 0.27 | Above forecast↑0.86 | $131.7M | $452M |
| Apr 30, 2025 | -- | -1.11 | Above forecast↑-0.75 | $150.6M | $131.6M |
| Feb 19, 2025 | -- | -1.09 | Above forecast↑-0.66 | $131.1M | $226.6M |
| Nov 6, 2024 | -- | -1.16 | Above forecast↑-0.95 | $144.4M | $133.8M |
| Aug 1, 2024 | -- | -0.92 | Above forecast↑-0.45 | $150.1M | $225.3M |
| May 7, 2024 | -- | -1.05 | Above forecast↑-0.98 | $131.4M | $119M |
| Feb 21, 2024 | -- | -0.83 | Above forecast↑-0.06 | $174.8M | $324.5M |
| Nov 2, 2023 | -- | -1.04 | Above forecast↑-1.03 | $132.9M | $144.2M |
| Aug 9, 2023 | -- | -0.90 | Above forecast↑-0.60 | $138.8M | $188.4M |
| May 3, 2023 | -- | -0.91 | Above forecast↑-0.87 | $140.5M | $130.5M |
| Feb 22, 2023 | -- | -1.06 | Above forecast↑-0.37 | $160.1M | $151.9M |
Original Filings (SEC)
Quarterly10-Q · 2026-07-29 ↗
Earnings Release8-K · 2026-07-29 ↗
Quarterly10-Q · 2026-04-29 ↗
Earnings Release8-K · 2026-04-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
